Jonathan Stuart, DO
Pain Medicine · Bartlett, TNNPI 1841470176
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Nevro Corp. at 41.0% of the total. Reporting peaked in 2019 at $4,581 and has fallen 93.6% since, to $293 in 2025.
Across 74 payments — averaging $81.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Arthrex$2K
- Gentleman Orthopedic Solutions$962
- Amgen$382
- Medtronic$144
- Globus Medical$100
- plus $67 from 1 others
What the payments were for
- Travel & lodging$2,04534%
- Food & beverage$2,11835%
- Education$1,87231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 56 | $2,476 |
| Arthrex | 4 | $1,904 |
| Gentleman Orthopedic Solutions | 4 | $962 |
| Amgen | 5 | $382 |
| Medtronic | 2 | $144 |
| Globus Medical | 2 | $100 |
| Tonix Medicines, Inc. | 1 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$1,534
- EVENITY$135
- INCEPTIV$125
How this compares
$6,035 in reported general payments places this provider in the 65th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 371 | $2,712 |
| Pregabalin | 141 | $2,220 |
| Celecoxib | 41 | $577 |
| Tramadol Hcl | 184 | $525 |
| Duloxetine Hcl | 37 | $503 |
| Methylprednisolone | 73 | $379 |
| Tizanidine Hcl | 59 | $300 |
| Diclofenac Sodium | 35 | $287 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $280 |
| Meloxicam | 83 | $263 |
| Ibuprofen | 22 | $217 |
| Doxycycline Monohydrate | 12 | $122 |
| Naproxen | 22 | $112 |
| Baclofen | 19 | $94 |
| Cyclobenzaprine Hcl | 32 | $53 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Bartlett
- Shravani DurbhakulaNashville$353K
- Joseph DichiaraKnoxville$102K
- Stephanie VanterpoolKnoxville$69K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
- Puneet MishraNashville$32K
- John BlakeChattanooga$28K
- Andrew DudasMemphis$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.